Flovent
Product Images NDC 50090-0910

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-0910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Floventhfa Spl Graphic 01)

Chemical structure diagram of the active ingredient in FLOVENT HFA, showing a complex steroid-based molecular framework with multiple hydroxyl, fluorine, and ester functional groups.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Floventhfa Spl Graphic 02)

A line graph showing the percentage change from baseline in FEV1 over 12 weeks plus an endpoint. Two data series are plotted: Placebo (diamonds) and FLOVENT HFA 88 mcg twice daily (squares). The x-axis represents weeks from 0 to 12 and an endpoint, while the y-axis shows percent change from baseline in FEV1 from 0 to 20 percent. FLOVENT HFA demonstrates a higher percentage increase in FEV1 compared to placebo throughout the study period.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Floventhfa Spl Graphic 03)

A line graph depicting the percentage change from baseline in FEV1 over 12 weeks for placebo and FLOVENT HFA at doses of 88 mcg, 220 mcg, and 440 mcg twice daily. The graph shows increasing improvement trends for all FLOVENT HFA dosages compared to placebo, with the highest dose showing the greatest change.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Floventhfa Spl Graphic 04)

A bar chart comparing the percentage of subjects achieving 100% reduction in dose and the percentage of subjects with an increase in dose across three groups: Placebo, FLOVENT HFA 440 mcg twice daily, and FLOVENT HFA 880 mcg twice daily. The chart includes distinct fill patterns and labels for each group.*

FDA Label Image

Figure A (Floventhfa Spl Graphic 05)

Illustration showing the components of a FLOVENT HFA metered-dose inhaler labeled with a metal canister, plastic actuator, mouthpiece, dose counter, and a separate cap. Each part is clearly identified with pointers in a simple line drawing.*

FDA Label Image

Figure B (Floventhfa Spl Graphic 06)

An instructional diagram showing two hands: one hand holding a removable cap and the other hand holding a metered-dose inhaler device. The illustration indicates removing the cap from the inhaler, with a left-pointing arrow between the cap and the device.*

FDA Label Image

Fgure C (Floventhfa Spl Graphic 07)

Instructional illustration showing how to use a FLOVENT HFA inhaler spray. It depicts a person holding the inhaler upright with an arrow indicating to press down on the top to release the spray aimed away from the face.*

FDA Label Image

Figure D (Floventhfa Spl Graphic 08)

An illustration showing a hand holding a FLOVENT HFA inhaler. The inhaler has a dose counter display indicating the number 120, representing the remaining doses in the inhaler.*

FDA Label Image

Figure E (Floventhfa Spl Graphic 09)

An instructional diagram showing the mouthpiece-down position of a FLOVENT HFA inhaler. The image labels the mouthpiece and a separate cap placed next to the inhaler, illustrating correct handling or positioning for use.*

FDA Label Image

Figure F (Floventhfa Spl Graphic 10)

An instructional illustration showing a side profile of a person's face with an arrow indicating to breathe out as much air as possible, likely part of usage directions for an inhaler product.*

FDA Label Image

Figure G (Floventhfa Spl Graphic 11)

An instructional illustration showing how to use an inhaler, depicting a person holding the inhaler close to the mouth with an arrow indicating to push down on the inhaler while breathing in. Text above the image reads, 'Push down and breathe in.'*

FDA Label Image

Figure H (Floventhfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth and spitting water into a sink, next to a running faucet and a glass of water. This image is likely intended to demonstrate proper oral rinsing technique, which can be associated with the use of inhalation medications like FLOVENT HFA.*

FDA Label Image

Figure I (Floventhfa Spl Graphic 13)

An instructional illustration showing the difference between a properly functioning and a blocked inhaler nozzle. The top image labeled "Not blocked" depicts the inhaler releasing a visible spray, while the bottom image labeled "Blocked" shows no spray being emitted from the inhaler.*

FDA Label Image

Floventhfa Spl Graphic 14

An instructional illustration showing a hand holding a cleaning swab or tool near the mouthpiece of an inhaler device. The diagram indicates a rotational movement around the mouthpiece area, suggesting a cleaning or maintenance action for the inhaler.*

FDA Label Image

Label Image (Lbl500900910)

Packaging label of FLOVENT HFA 110 mcg (inhalation aerosol) by A-S Medication Solutions. The label includes storage instructions, dosage information indicating 120 metered actuations, and manufacturer details as GlaxoSmithKline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.